Cargando…
Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada
Aims. To assess trends in the incidence of pediatric diarrhea-associated hemolytic uremic syndrome (D(+) HUS) and document long-term renal sequelae. Methods. We conducted a retrospective cohort study of children with D(+) HUS admitted to a tertiary care pediatric hospital in Montreal, Canada, from 1...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820622/ https://www.ncbi.nlm.nih.gov/pubmed/24278685 http://dx.doi.org/10.6064/2012/341860 |
_version_ | 1782290171313520640 |
---|---|
author | Robitaille, Pierre Clermont, Marie-José Mérouani, Aïcha Phan, Véronique Lapeyraque, Anne-Laure |
author_facet | Robitaille, Pierre Clermont, Marie-José Mérouani, Aïcha Phan, Véronique Lapeyraque, Anne-Laure |
author_sort | Robitaille, Pierre |
collection | PubMed |
description | Aims. To assess trends in the incidence of pediatric diarrhea-associated hemolytic uremic syndrome (D(+) HUS) and document long-term renal sequelae. Methods. We conducted a retrospective cohort study of children with D(+) HUS admitted to a tertiary care pediatric hospital in Montreal, Canada, from 1976 to 2010. In 2010, we recontacted patients admitted before 2000. Results. Of 337 cases, median age at presentation was 3.01 years (range 0.4–14). Yearly incidence peaked in 1988 and 1994-95, returning to near-1977 levels since 2003. Twelve patients (3.6%) died and 19 (5.6%) experienced long-term renal failure. Almost half (47%) The patients required dialysis. Need for dialysis was the best predictor of renal sequelae, accounting for 100% of severe complications. Of children followed ≥1 year (n = 199, mean follow-up 8.20 ± 6.78 years), 19 had severe and 18 mild-to-moderate kidney injury, a total sequelae rate, of 18.6%. Ten years or more after-HUS (n = 85, mean follow-up 15.4 ± 5.32 years), 8 (9.4%) patients demonstrated serious complications and 22 (25.9%) mild-to-moderate, including 14 (16%) microalbuminuria: total sequelae, 35.3%. Conclusions. Patients with D(+) HUS should be monitored at least 5 years, including microalbuminuria testing, especially if dialysis was required. The cause of the declining incidence of D(+)HUS is elusive. However, conceivably, improved public health education may have played an important role in the prevention of food-borne disease. |
format | Online Article Text |
id | pubmed-3820622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38206222013-11-25 Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada Robitaille, Pierre Clermont, Marie-José Mérouani, Aïcha Phan, Véronique Lapeyraque, Anne-Laure Scientifica (Cairo) Clinical Study Aims. To assess trends in the incidence of pediatric diarrhea-associated hemolytic uremic syndrome (D(+) HUS) and document long-term renal sequelae. Methods. We conducted a retrospective cohort study of children with D(+) HUS admitted to a tertiary care pediatric hospital in Montreal, Canada, from 1976 to 2010. In 2010, we recontacted patients admitted before 2000. Results. Of 337 cases, median age at presentation was 3.01 years (range 0.4–14). Yearly incidence peaked in 1988 and 1994-95, returning to near-1977 levels since 2003. Twelve patients (3.6%) died and 19 (5.6%) experienced long-term renal failure. Almost half (47%) The patients required dialysis. Need for dialysis was the best predictor of renal sequelae, accounting for 100% of severe complications. Of children followed ≥1 year (n = 199, mean follow-up 8.20 ± 6.78 years), 19 had severe and 18 mild-to-moderate kidney injury, a total sequelae rate, of 18.6%. Ten years or more after-HUS (n = 85, mean follow-up 15.4 ± 5.32 years), 8 (9.4%) patients demonstrated serious complications and 22 (25.9%) mild-to-moderate, including 14 (16%) microalbuminuria: total sequelae, 35.3%. Conclusions. Patients with D(+) HUS should be monitored at least 5 years, including microalbuminuria testing, especially if dialysis was required. The cause of the declining incidence of D(+)HUS is elusive. However, conceivably, improved public health education may have played an important role in the prevention of food-borne disease. Hindawi Publishing Corporation 2012 2012-12-31 /pmc/articles/PMC3820622/ /pubmed/24278685 http://dx.doi.org/10.6064/2012/341860 Text en Copyright © 2012 Pierre Robitaille et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Robitaille, Pierre Clermont, Marie-José Mérouani, Aïcha Phan, Véronique Lapeyraque, Anne-Laure Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada |
title | Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada |
title_full | Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada |
title_fullStr | Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada |
title_full_unstemmed | Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada |
title_short | Hemolytic Uremic Syndrome: Late Renal Injury and Changing Incidence—A Single Centre Experience in Canada |
title_sort | hemolytic uremic syndrome: late renal injury and changing incidence—a single centre experience in canada |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820622/ https://www.ncbi.nlm.nih.gov/pubmed/24278685 http://dx.doi.org/10.6064/2012/341860 |
work_keys_str_mv | AT robitaillepierre hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada AT clermontmariejose hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada AT merouaniaicha hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada AT phanveronique hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada AT lapeyraqueannelaure hemolyticuremicsyndromelaterenalinjuryandchangingincidenceasinglecentreexperienceincanada |